glp-1 receptor agonists blindness risk Eye doctors warn drugs for diabetes and weight loss may pose rare vision risks, recommending regular checkups GLP-1 Drugs and Ocular Disease:
Description
Medications like Wegovy (semaglutide) and Mounjaro (tirzepatide, which is a dual GLP-1/GIP agonist) are administered just once a week using a small, pre-filled injection pen
They should seek medical advice if such adverse effects are severe, or occur for an extended period, so that their provider may consider dose adjustment (when applicable), discontinuation, or alternative therapies (63)
[DOI] [PubMed] [Google Scholar] 12.Filippatos TD, Liberopoulos EN, Kostapanos M, Gazi IF, Papavasiliou EC, Kiortsis DN, Tselepis AD, Elisaf MS
About one-third of patients with gastroparesis have diabetes [21]
Dan Med J
Morel, Genve (Chirurgie)
